TY  - GEN 
AU  - Martínez Pérez, María
AU  - Nieto-Sánchez, María Teresa
AU  - Díaz Villamarín, Xando
AU  - Torres García, Alicia
AU  - Fernández Varón, Emilio
AU  - Prados-Carmona, Alvaro
AU  - Legerén, Marta
AU  - Cabeza-Barrera, José
AU  - Blancas López-Barajas, María Isabel
AU  - Morón Romero, María Rocío
PY  - 2026
UR  - https://hdl.handle.net/10481/111495
AB  - Background/Objectives: Sacituzumab govitecan (SG) releases SN-38, the same active me
tabolite as irinotecan, thereby sharing key metabolic pathways and toxicity mechanisms. 
The clearance of SN-38 is strongly influenced by UGT1A1 polymorphisms,...
LA  - eng
PB  - MDPI
KW  - sacituzumab-govitecan
KW  - UGT1A128
KW  - pharmacogenetics
TI  - The Early Safety Signal of Sacituzumab Govitecan-Related Toxicity and the UGT1A128 Genotype in Metastatic Breast Cancer: A Real-World Preliminary Report
DO  - 10.3390/jcm15051715
ER  -